The International Day of Women and Girls in Science, celebrated on Feb. 11, promotes full and equal access to and participation in science for women and girls, as well as honoring the achievements of women in the field.
According to the United Nations Educational, Scientific and Cultural Org (UNESCO0 Science Report, women account for only 33% of the world’s researchers1. Here at Vitalant, women play vital roles across the organization, including at the Vitalant Research Institute.
Each year, America’s Blood Centers (ABC) recognizes individuals, civic groups, media and corporations for their commitment to community and national blood programs through their Awards of Excellence program.
Vitalant has been recognized with two awards this year: The illustrious Thomas F. Zuck Lifetime Achievement Award for Dr. Michael P. Busch and Outstanding Public Relations Campaign for the COVID Rescue Team.
The largest nationwide SARS-CoV-2 seroprevalence survey, funded by the CDC and supported by 17 blood collection organizations representing blood donations from across all 50 states, Washington D.C., and Puerto Rico, published its latest findings in the Journal of the American Medical Association (JAMA). More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
Vitalant is launching the Vitalant Innovation Center in Denver, Colorado, a key part of the Vitalant Research Institute. Vitalant is investing in the Innovation Center as part of its commitment to advancing the science of transfusion medicine. The center will provide scientific research and translational development expertise to design innovative processes for Vitalant and bring new products to the patients it serves.
Blood collection organizations, testing laboratories and affiliated research institutes continue to play a critical role in the response to the COVID-19 pandemic, and blood centers across the country are proud to be at the forefront.
Antibodies are one of the ways the human body fights infection from the coronavirus. Researchers believe testing for covid-19 antibodies can lead to possible treatments for the virus and help indicate when to reopen society.